James Richman Says OTLEN Invited to Join Anthropic’s Claude Partner Network
OTLEN, a healthcare AI infrastructure company led by Chief Executive Officer James Richman, has been invited to join Anthropic’s Claude Partner Network, according to the company and its Chief Executive Officer, Richman, a move that would expand its use of Claude-based AI agents across hospital systems and private clinics.
OTLEN describes itself as a provider of what it calls a “central nervous system” for healthcare operations, built on vertical AI tools designed to integrate fragmented hospital and clinic systems. The company operates across two main segments: large biopharma firms and health systems, where it targets what it terms the “Billion Dollar Handoff” between research, clinical, and commercial data; and small and mid-sized private clinics, primarily in Southeast Asia, where it has reported revenue-per-patient increases of 150 to 300 percent over 24-month engagements through automated revenue operations.
Anthropic, the AI safety company behind the Claude family of models, runs a partner network for organizations building agentic and long-context AI applications. Partner status typically involves deeper technical collaboration, expanded model access, and joint development on specialized use cases.
Enterprise Focus
For large health systems and biopharma clients, OTLEN says it deploys AI agents to unify research, clinical trial, and commercial data that often sit in separate systems. The company has previously cited an estimated $350 billion in annual losses across the industry tied to revenue leakage and operational silos.
According to OTLEN, Claude-based agents will be used to support long-horizon reasoning across multi-step revenue cycle workflows in regulated environments
“This strengthens our ability to run safer, more reliable agent networks inside regulated healthcare environments, connecting decision-making from the lab to the balance sheet,” Richman said.
Private Clinic Segment
The diverse portfolio of OTLEN’s other clients – which includes various private clinics and surgical centers, many including Southeast Asia -must navigate a unique set of operational pressures.
According to the company, these smaller and mid-sized healthcare providers often operate on remarkably thin margins, frequently coupled with high patient turnover and a business model that sees limited repeat patient engagement.
By joining Anthropic’s Claude Partner Network, OTLEN plans to deploy Claude-powered AI agents to address these specific challenges by automating historically manual tasks such as patient intake, follow-up scheduling, and account maintenance.
This initiative aims to adapt the robust AI infrastructure used by billion-dollar enterprises into an “invisible overlay” for smaller clinics, effectively lifting revenue-per-patient by 150 to 300 percent while allowing medical staff to focus more on direct patient care.
OTLEN said Claude-powered AI agents are expected to increasingly handle patient intake, follow-up scheduling, and account maintenance for these smaller providers, work that has historically been manual.
“The same infrastructure used in billion-dollar enterprises can be adapted as an invisible overlay for small clinics, automating revenue operations while freeing staff to focus on patients,” Richman said.
Why Anthropic
OTLEN said its decision to expand its use of Claude was driven in part by Anthropic’s emphasis on model alignment, safety guardrails, and long-context reasoning – factors the company said are relevant in healthcare settings where auditability and predictable system behavior are required.
The healthcare sector has been slower than some industries to adopt agentic AI, with providers citing concerns about reliability and oversight in environments where errors carry higher consequences than in other sectors.
Wider Trend
The announcement of OTLEN’s invitation to Anthropic’s Claude Partner Network occurs during a period of significant expansion in agentic AI deployment across high-stakes sectors like financial services, logistics, and healthcare.
As the industry moves toward more sophisticated autonomous workflows, investors and operators have shifted their focus toward technology-enabled services models.
In these models, a robust AI infrastructure acts as a foundational layer that can simultaneously support complex, large-scale enterprise systems while also providing critical operational stability for fragmented networks of smaller healthcare providers.
This trend reflects a broader move toward unifying disparate operational silos through intelligent, long-context reasoning agents that can handle multi-step tasks in regulated environments.
What’s Next
OTLEN said it plans to roll out Claude-based capabilities across its enterprise clients and private clinic partners in phases. Financial terms of the partnership were not disclosed.
Ultimately, while OTLEN’s expansion into AI-driven healthcare operations through this partnership represents a significant step forward, the broader industry will be watching to see how successfully these agentic workflows translate into measurable improvements for patient outcomes and operational efficiency.
